Independent Longevity Research

Longevity Clinics, Tests, Costs, and Evidence

See what a longevity offer includes, what it costs, who provides medical oversight, and which parts are established care versus expensive uncertainty.

Provider profiles are researched independently from current public prices and official service pages. Inclusion is not an endorsement.

Longevity companies sell bundles. Age Life Forward pulls those bundles apart. We record the price, tests, clinician involvement, source date, and evidence limit separately so a polished offer cannot make every component look equally proven.

More testing is not automatically more prevention.

The useful question is not which clinic sounds most advanced. It is which part of the offer can change a decision for someone with your age, symptoms, family history, and baseline risk.

Price before the sales call

We record posted entry prices, promotional pricing, annual commitments, and when a provider keeps the price behind an inquiry.

Tests by actual tradeoff

Whole-body CT, MRI, biomarker panels, genomics, and biological age tests are compared by radiation, false positives, repeatability, and what happens next.

Claims by evidence level

Standard preventive care, risk-specific screening, exploratory measurement, and unapproved treatment do not share one proof standard.

A scan result is not finished when the scan ends.

A finding can lead to repeat imaging, specialist visits, biopsies, anxiety, and cost. A normal result can create false reassurance. The quality of the follow-up plan matters as much as the technology being sold.

Know who reads it

Ask which licensed clinician interprets the test, who receives the report, and who owns follow-up when the result is unclear.

Know what changes

Ask which possible results would change treatment and which would only create another measurement to watch.

Keep ordinary prevention

Elective longevity testing does not replace age-appropriate screening, symptom evaluation, vaccination, or management of known risk.

The bundle gets separated before it gets judged.

A provider can combine proven risk management, reasonable but context-dependent screening, exploratory biomarkers, and unsupported longevity treatment in the same membership.

  • Provider facts come from current official pages and carry a source-check date.
  • Provider claims stay labeled as claims until outside evidence supports them.
  • Price transparency is recorded separately from clinical quality.
  • No provider receives a better conclusion for payment or inclusion.

Prices change. Evidence changes more slowly.

The comparison dataset is built to be updated when providers change prices, locations, tests, or terms. Evidence guides change when regulators, medical societies, systematic reviews, or useful human trials change the decision.

  • New posted prices and program inclusions
  • Changes in medical oversight or availability
  • Whole-body screening outcome evidence
  • Independent validation of biological age tools

Longevity Tests and Costs

Are Full-Body Scans Worth It? A Buyer Decision Guide

September 9, 2026

Longevity Tests and Costs

Epigenetic Age Test Cost and Accuracy

September 9, 2026

Longevity Tests and Costs

Full-Body CT vs MRI for Longevity Screening

September 9, 2026

Longevity Tests and Costs

Longevity Clinic Costs: Current Prices and What You Get

September 9, 2026

Clinics and Programs

What Advanced Longevity Means: Clinics, Programs, Tests, and the Evidence Behind Them

September 2, 2026

Get the changes that could alter a buying decision.

Join for material price changes, new provider comparisons, and evidence updates. No daily longevity headlines and no clinic sales sequence.

Educational publication: Age Life Forward is an independent educational publication. It does not provide medical advice, diagnosis, treatment, rankings, or endorsements.